Clinical Trial Update: Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications [Phase 4]

View source ↗

Summary

This Phase 4 update reports outcomes from hyperbaric oxygen therapy across several emerging indications, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Frostbite
• Post-covid-19 Condition
• Pterygium
• Pyoderma Gangrenosum
• Raynaud Syndrome
• Ulcerative Colitis

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: Jay C. Buckey Jr. | Conditions: Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Status: NOT_YET_RECRUITING